Subscribe To
ACST / Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting
Content Topics
Acasti
Present
Gtx
104
Pharmacokinetic
Comparison
Data
Gtx 104
Neurocritical
Annual
Meeting
Stock
ACST
ACST News
By GlobeNewsWire
August 9, 2023
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting
PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) ("Acasti" or the "Company"), a late-stage, biopharma company adva more_horizontal
By Seeking Alpha
February 14, 2023
Acasti Pharma Inc. (ACST) Q3 2023 Earnings Call Transcript
Acasti Pharma Inc. (NASDAQ:ACST ) Q3 2023 Earnings Conference Call February 14, 2023 1:00 PM ET Company Representatives Jan D'Alvise - President, Chie more_horizontal
By Seeking Alpha
November 14, 2022
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript
Acasti Pharma Inc. (NASDAQ:ACST ) Q2 2023 Earnings Conference Call November 14, 2022 1:00 PM ET Company Participants Robert Blum - Lytham Partners, IR more_horizontal
By GlobeNewsWire
June 16, 2022
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time more_horizontal
By Benzinga
May 18, 2022
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
Acasti Pharma Inc's (NASDAQ: ACST) pharmacokinetic (PK) bridging study with IV GTX-104, its lead drug candidate for Subarachnoid Hemorrhage (SAH), m more_horizontal
By Seeking Alpha
February 14, 2022
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
February 14, 2022
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
February 14, 2022
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript more_horizontal